I Cortese Selected Research

CGP 77116

10/2000

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Cortese Research Topics

Disease

4	Multiple Sclerosis 10/2001 - 10/2000
1	Central Nervous System Diseases (CNS Diseases) 01/2011
1	Chorea (Rheumatic Chorea) 01/2011
1	Guillain-Barre Syndrome 01/2011
1	Infections 01/2011
1	Polyneuropathies (Polyneuropathy) 01/2011
1	Chronic Progressive Multiple Sclerosis 01/2011
1	Myasthenia Gravis 01/2011
1	Nervous System Diseases (Neurological Disorders) 01/2011
1	Progressive Multifocal Leukoencephalopathy 01/2006
1	Virus Diseases (Viral Diseases) 02/2001

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 10/2001 - 10/2000
2	Peptides (Polypeptides)IBA 02/2001 - 10/2000
1	Interferon-betaIBA 01/2006
1	Oligoclonal BandsIBA 02/2001
1	AntibodiesIBA 02/2001
1	CGP 77116IBA 10/2000
1	Myelin Basic ProteinIBA 10/2000
1	Amino Acids FDA Link 10/2000
1	LigandsIBA 10/2000

Therapy/Procedure

1	Therapeutics 01/2011
1	Plasmapheresis 01/2011
1	Immunotherapy 10/2000